Back to Search
Start Over
Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study
- Source :
- Veterinary Quarterly, Vol 44, Iss 1, Pp 1-7 (2024)
- Publication Year :
- 2024
- Publisher :
- Taylor & Francis Group, 2024.
-
Abstract
- AbstractPancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. The AP group (n = 40) consisted of dogs with AP diagnosed using clinical signs and laboratory examinations, including abnormal canine pancreatic lipase (cPL) concentration, and compatible abdominal ultrasound examination at first presentation. Evaluation of the canine AP severity (CAPS) score was performed. The control group (n = 38) was composed of normal dogs without any abnormalities in clinical findings, blood exams or diagnostic imaging. The correlation of P-AMY with cPL was confirmed by Pearson’s correlation analysis (r = 0.564, p
- Subjects :
- Acute pancreatitis
dogs
pancreatic-alpha amylase
Veterinary medicine
SF600-1100
Subjects
Details
- Language :
- English
- ISSN :
- 01652176 and 18755941
- Volume :
- 44
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Veterinary Quarterly
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9cdcde9058724b48bd561b4d0670d34c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1080/01652176.2024.2326007